Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
5.53
+0.22 (4.14%)
At close: Dec 24, 2025, 1:00 PM EST
5.40
-0.13 (-2.35%)
After-hours: Dec 24, 2025, 4:53 PM EST
Ekso Bionics Holdings Market Cap
Ekso Bionics Holdings has a market cap or net worth of $18.56 million as of December 24, 2025. Its market cap has increased by 24.55% in one year.
Market Cap
18.56M
Enterprise Value
20.79M
1-Year Change
24.55%
Ranking
Category
Stock Price
$5.53
Market Cap Chart
Since January 17, 2014, Ekso Bionics Holdings's market cap has increased from $15.60M to $18.56M, an increase of 18.96%. That is a compound annual growth rate of 1.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 13.90M | 3.73% |
| Dec 31, 2024 | 13.40M | -62.36% |
| Dec 29, 2023 | 35.60M | 128.21% |
| Dec 30, 2022 | 15.60M | -53.57% |
| Dec 31, 2021 | 33.60M | -34.12% |
| Dec 31, 2020 | 51.00M | 74.06% |
| Dec 31, 2019 | 29.30M | -62.29% |
| Dec 31, 2018 | 77.70M | -39.11% |
| Dec 29, 2017 | 127.60M | 46.50% |
| Dec 30, 2016 | 87.10M | -16.57% |
| Dec 31, 2015 | 104.40M | -2.34% |
| Dec 31, 2014 | 106.90M | 585.26% |
| Jan 17, 2014 | 15.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |